Proconvulsant Effect of NUCB2/Nesfatin-1
| dc.authorid | Erken, Haydar Ali/0000-0003-0103-4096|Ayada, Ceylan/0000-0002-6272-4173|Erken, Gulten/0000-0001-9234-7762|Turgut, Gunfer/0000-0002-6329-4398|Turgut, Sebahat/0000-0002-7884-5623|Turgut, Sebahat/0000-0002-7629-2631 | |
| dc.contributor.author | Erken, Haydar Ali | |
| dc.contributor.author | Koc, Emine Rabia | |
| dc.contributor.author | Erken, Gulten | |
| dc.contributor.author | Genc, Osman | |
| dc.contributor.author | Celik, Huseyin Tugrul | |
| dc.contributor.author | Gokce, Emre Cemal | |
| dc.contributor.author | Ayada, Ceylan | |
| dc.date.accessioned | 2025-10-24T18:08:50Z | |
| dc.date.available | 2025-10-24T18:08:50Z | |
| dc.date.issued | 2015 | |
| dc.department | Malatya Turgut Özal Üniversitesi | |
| dc.description.abstract | NUCB2/nesfatin-1 has been implicated in various physiological functions such as feeding, drinking and the sleep-wake cycle, but its effect on epileptic activity is not clear. The aim of this study was to investigate the effects of NUCB2/nesfatin-1 on penicillin-induced epileptic activity and to answer the question of whether only NUCB2/nesfatin-1 cause epileptic activity in rats. Thirty-five rats were randomly assigned to the following seven groups: control, saline, penicillin, two different doses of NUCB2/nesfatin-1 (100 and 300 pmol), penicillin and two different doses of NUCB2/nesfatin-1 (100 and 300 pmol). EEGs were recorded before the injections and during the following 120 min. The EEG and motor findings of epileptic seizures were observed in NUCB2/nesfatin-1-injected groups. NUCB2/nesfatin-1 significantly increased the EEG power spectrum, spike frequency and amplitude values in penicillin-induced epileptic rats. These findings indicate that NUCB2/nesfatin-1 both causes epileptic activity and increases penicillin-induced epileptic activity in rats. | |
| dc.identifier.doi | 10.1007/s10989-014-9428-6 | |
| dc.identifier.endpage | 38 | |
| dc.identifier.issn | 1573-3149 | |
| dc.identifier.issn | 1573-3904 | |
| dc.identifier.issue | 1 | |
| dc.identifier.scopus | 2-s2.0-84933041744 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 29 | |
| dc.identifier.uri | https://doi.org/10.1007/s10989-014-9428-6 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12899/3334 | |
| dc.identifier.volume | 21 | |
| dc.identifier.wos | WOS:000348448700005 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Springer | |
| dc.relation.ispartof | International Journal Of Peptide Research And Therapeutics | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_20251023 | |
| dc.subject | EEG; Epilepsy; Nesfatin-1; NUCB2; Seizure | |
| dc.title | Proconvulsant Effect of NUCB2/Nesfatin-1 | |
| dc.type | Article |












